DVH analyses at urination between before and after by using 4DCT for the patients with prostate cancer

DVH analyses at urination between before and after by using 4DCT for the patients with prostate cancer - DVH analyses at urination between before and after by using 4DCT for the patients with prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039430

Enrollment

Registered

2020-02-10

Start date

2020-02-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)The patients who are treated with carbon-ion radiotherapy 2) Patients who hope to participate in this study

Exclusion criteria

Exclusion criteria: 1) having abnormal by examination after concent 2) Patients who have difficulty performing CT imaging 3) Patient after femoral head replacement 4)Those who are judged by the doctor to be ineligible for the study.

Design outcomes

Primary

Measure	Time frame
The dose to bladder and rectum and planning target volume according to DVH analyses	—

Countries

Japan

Contacts

Public ContactGoro Kasuya

QST hospital treatment section

kasuya.goro@qst.go.jp04320633306

Outcome results